Molecular characterization of penicillin non-susceptible Streptococcus pneumoniae isolated before and after pneumococcal conjugate vaccine implementation in Casablanca, Morocco

[1]  F. Chang,et al.  Important Mutations Contributing to High-Level Penicillin Resistance in Taiwan19F-14, Taiwan23F-15, and Spain23F-1 of Streptococcus pneumoniae Isolated from Taiwan. , 2016, Microbial drug resistance.

[2]  M. Timinouni,et al.  Phenotypic and genotypic characterization of Streptococcus pneumoniae resistant to macrolide in Casablanca, Morocco. , 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[3]  Z. Zhang,et al.  Molecular characteristics of penicillin-binding protein 2b, 2x and 1a sequences in Streptococcus pneumoniae isolates causing invasive diseases among children in Northeast China , 2016, European Journal of Clinical Microbiology & Infectious Diseases.

[4]  K. Katfy,et al.  Invasive pneumococcal disease among children younger than 5 years of age before and after introduction of pneumococcal conjugate vaccine in Casablanca, Morocco. , 2015, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[5]  Á. Gentile.  [Effects of vaccination on invasive pneumococcal disease in South Africa]. , 2015, Archivos argentinos de pediatria.

[6]  M. Martinez,et al.  Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation. , 2013, Vaccine.

[7]  S. Richter,et al.  Pneumococcal Serotypes before and after Introduction of Conjugate Vaccines, United States, 1999–2011 , 2013, Emerging infectious diseases.

[8]  J. Parkhill,et al.  Pneumococcal Capsular Switching: A Historical Perspective , 2012, The Journal of infectious diseases.

[9]  M. Gilmour,et al.  Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012. , 2012, Canadian journal of microbiology.

[10]  H. B. DemczukWalter,et al.  Serotype distribution of invasive Streptococcus pneumoniae in Canada during the introduction of the 13-valent pneumococcal conjugate vaccine, 2010 , 2012 .

[11]  Who Publication.  Pneumococcal vaccines WHO position paper - 2012 - recommendations. , 2012, Vaccine.

[12]  T. Tan.  Pediatric Invasive Pneumococcal Disease in the United States in the Era of Pneumococcal Conjugate Vaccines , 2012, Clinical Microbiology Reviews.

[13]  R. Dagan,et al.  The relationship between pneumococcal serotypes and antibiotic resistance. , 2012, Vaccine.

[14]  J. Liñares,et al.  Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[15]  R. Dagan,et al.  Impact of conjugate pneumococcal vaccines on antibiotic resistance. , 2008, The Lancet. Infectious diseases.

[16]  F. Baquero,et al.  Alterations of the penicillin-binding proteins and murM alleles of clinical Streptococcus pneumoniae isolates with high-level resistance to amoxicillin in Spain. , 2006, The Journal of antimicrobial chemotherapy.

[17]  C. Bloch,et al.  Genomic analysis of penicillin-resistant Streptococcus pneumoniae in Southeastern Michigan. , 2004, The Journal of infection.

[18]  J. Klena,et al.  Molecular characterization of penicillin non-susceptible Streptococcus pneumoniae in Christchurch, New Zealand. , 2004, The Journal of antimicrobial chemotherapy.

[19]  P. Appelbaum.  Resistance among Streptococcus pneumoniae: Implications for drug selection. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  Michael R. Jacobs,et al.  Effects of Amino Acid Alterations in Penicillin-Binding Proteins (PBPs) 1a, 2b, and 2x on PBP Affinities of Penicillin, Ampicillin, Amoxicillin, Cefditoren, Cefuroxime, Cefprozil, and Cefaclor in 18 Clinical Isolates of Penicillin-Susceptible, -Intermediate, and -Resistant Pneumococci , 2002, Antimicrobial Agents and Chemotherapy.

[21]  R. de Groot,et al.  Molecular Epidemiology of Penicillin-NonsusceptibleStreptococcus pneumoniae among Children in Greece , 2000, Journal of Clinical Microbiology.

[22]  J. Elliott,et al.  Sudden Increase in Isolation of Group B Streptococci, Serotype V, Is Not Due to Emergence of a New Pulsed-Field Gel Electrophoresis Type , 1998, Journal of Clinical Microbiology.

[23]  C. Dowson,et al.  Genetics of high level penicillin resistance in clinical isolates of Streptococcus pneumoniae. , 1995, FEMS microbiology letters.

[24]  A. Tomasz,et al.  Penicillin-binding proteins of penicillin-susceptible and -resistant pneumococci: immunological relatedness of altered proteins and changes in peptides carrying the beta-lactam binding site , 1986, Antimicrobial Agents and Chemotherapy.

[25]  D. Hansman,et al.  A RESISTANT PNEUMOCOCCUS , 1967 .

[26]  Bourdillon Jf.  PHENOTHIAZINE DYSKINESIA AFTER LEUCOTOMY. , 1964, Lancet.

[27]  C. Whitney,et al.  Major related sets of antibiotic-resistant Pneumococci in the United States as determined by pulsed-field gel electrophoresis and pbp1a-pbp2b-pbp2x-dhf restriction profiles. , 2000, The Journal of infectious diseases.

[28]  M. P. van der Linden,et al.  Penicillin-binding proteins in beta-lactam-resistant streptococcus pneumoniae. , 1999, Microbial drug resistance.

[29]  R. Hakenbeck,et al.  Penicillin-Binding Proteins in β-Lactam–Resistant Streptococcus pneumoniae , 1999 .

[30]  J. Ghuysen,et al.  Serine beta-lactamases and penicillin-binding proteins. , 1991, Annual review of microbiology.